Molecular parameters for precise diagnosis of asymptomatic Epstein-Barr virus reactivation in healthy carriers
about
Serological diagnosis of Epstein-Barr virus infection: Problems and solutionsDetection of EBV-DNA in serum samples of an immunosuppressed child during a three years follow-up: association of clinical and PCR data with active infection.Genetic factors affecting EBV copy number in lymphoblastoid cell lines derived from the 1000 Genome Project samples.Chronic Epstein-Barr virus-related hepatitis in immunocompetent patients.EBV Chronic InfectionsPositive correlation between Epstein-Barr virus viral load and anti-viral capsid immunoglobulin G titers determined for Hodgkin's lymphoma patients and their relativesSerological detection of human papillomavirus type 16 infection in human immunodeficiency virus (HIV)-positive and high-risk HIV-negative women.Validation of Roche LightCycler Epstein-Barr virus quantification reagents in a clinical laboratory setting.Immune and Epstein-Barr virus gene expression in cerebrospinal fluid and peripheral blood mononuclear cells from patients with relapsing-remitting multiple sclerosis.Laboratory assays for Epstein-Barr virus-related disease.Treatment-dependent loss of polyfunctional CD8+ T-cell responses in HIV-infected kidney transplant recipients is associated with herpesvirus reactivationEpstein-Barr virus: silent companion or causative agent of chronic liver disease?Determining EBV load: current best practice and future requirements.Detection of Herpesvirus, Enterovirus, and Arbovirus infection in patients with suspected central nervous system viral infection in the Western Brazilian Amazon.Real-Time PCR of cytomegalovirus and Epstein-Barr virus in adult Egyptian patients with systemic lupus erythematosus.Longitudinal analysis of frequency and reactivity of Epstein-Barr virus-specific T lymphocytes and their association with intermittent viral reactivation.Comparison of three automated immunoassay methods for the determination of Epstein-Barr virus-specific immunoglobulin M.Composite Epstein-Barr Virus-Associated B-Cell Lymphoproliferative Disorder and Tubular Adenoma in a Rectal Polyp.Associations of Epstein-Barr Virus DNA in PBMCs and the Subtypes with Breast Cancer Risk.Epstein-Barr virus in oral mucosa from human immunodeficiency virus positive patients.Impact of Epstein-Barr virus load, virus genotype, and frequency of the 30 bp deletion in the viral BNLF-1 gene in patients harboring the human immunodeficiency virus.Prevalence and molecular profiling of Epstein Barr virus (EBV) among healthy blood donors from different nationalities in Qatar.Longitudinal observation of Epstein-Barr virus antibodies in athletes during a competitive season.Specific CD8+ response discriminates presumed Epstein-Barr virus-related hepatitis and non-alcoholic fatty liver.Serum Epstein-Barr virus DNA load in primary Epstein-Barr virus infection.Whole transcriptome profiling reveals major cell types in the cellular immune response against acute and chronic active Epstein-Barr virus infection.HLA alleles modulate EBV viral load in multiple sclerosis.Epstein–Barr Virus Epidemiology, Serology, and Genetic Variability of LMP-1 Oncogene Among Healthy Population: An Update.
P2860
Q26829346-83419849-C817-4224-8C33-59DD64D9FA7FQ30989314-E238B1C0-D400-45B1-8A73-C6685402962EQ33842180-89E38F5D-9ACC-41EF-BC9D-DF80548581F2Q33869280-EB1140FD-8A71-4D46-B74E-5C0C2B22438CQ34171625-B0EC2780-3192-4176-81B2-3ECBBC74406CQ34315479-87C1ACE8-CD23-4E88-A1E7-387934B47497Q34601418-7072E073-F870-4CF2-89CE-D4416F954033Q35807886-CCB81F45-F6DB-4818-B6A7-4D2AF7290304Q35848490-D249F9DF-B103-457D-A756-DED98F6CD2E6Q37192117-0CCC0056-BBFD-47B3-A1D1-EC4252D5B234Q37352087-EE8E66B3-2739-4283-BBF6-AB06D15E2D4DQ37784165-41CD2ECC-34D0-4518-B4E7-F6B004DBA5DDQ38079834-5577559D-9D55-4BE0-85D1-1BCEF4411541Q38896290-2AAD60A8-E7E4-46E8-814A-49BB06F679AFQ39258006-6D6BA3FC-34DD-4A0F-9E87-498FF7D2D23BQ39441043-39012965-7997-4DFC-B280-243CF12327EEQ39894657-F50A473E-6FC7-44A5-A227-3254D928928DQ41008273-5066D639-0F29-4773-9C66-4618FD74D3E4Q41721691-4587D5A2-550A-447B-B313-194E837D568AQ42207455-96728AE7-87BB-411E-8A60-33BCE19018DAQ42271409-1B6C8DA6-71B2-4CE3-A6C0-00160B848FC8Q45323519-67ECA2D8-093C-4CA4-9273-4E39578ACBE6Q45355998-86EC6FF6-D550-44D1-8B60-74ADAD953A13Q45401018-68680AAD-1275-46F0-88B2-BBB88291C859Q45551051-B919ECE8-BE76-482D-B376-2931B3B1C7D1Q47146176-D422D080-34CD-41B7-BAF0-7D85F51E2F1FQ55017154-C01853CE-71FA-448A-BAC8-83974299BBC9Q55312268-A292431A-3E56-4F74-A15F-F8007AC59139
P2860
Molecular parameters for precise diagnosis of asymptomatic Epstein-Barr virus reactivation in healthy carriers
description
2003 nî lūn-bûn
@nan
2003 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2003 թվականի դեկտեմբերին հրատարակված գիտական հոդված
@hy
2003年の論文
@ja
2003年論文
@yue
2003年論文
@zh-hant
2003年論文
@zh-hk
2003年論文
@zh-mo
2003年論文
@zh-tw
2003年论文
@wuu
name
Molecular parameters for preci ...... activation in healthy carriers
@ast
Molecular parameters for preci ...... activation in healthy carriers
@en
Molecular parameters for preci ...... activation in healthy carriers
@nl
type
label
Molecular parameters for preci ...... activation in healthy carriers
@ast
Molecular parameters for preci ...... activation in healthy carriers
@en
Molecular parameters for preci ...... activation in healthy carriers
@nl
prefLabel
Molecular parameters for preci ...... activation in healthy carriers
@ast
Molecular parameters for preci ...... activation in healthy carriers
@en
Molecular parameters for preci ...... activation in healthy carriers
@nl
P2093
P2860
P1476
Molecular parameters for preci ...... activation in healthy carriers
@en
P2093
Hans-Joachim Wagner
Holger Hennig
Jürgen Steinhoff
Lutz Fricke
Peter Schlenke
Susanne Maurmann
Wolfram J Jabs
P2860
P304
P356
10.1128/JCM.41.12.5419-5428.2003
P407
P577
2003-12-01T00:00:00Z